Why Core Scientific, Inc. (CORZ) stock moved
Core Scientific, Inc. (CORZ) shares rose 3.1% to $13.51 as of October 27, 2026, a moderate gain from the prior close of $13.10. BestStocks flagged the session as a major change for CORZ. The move is tied to price move up. Below, we break down what changed for CORZ, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
CORZ climbed 3.1% to $13.51
CORZ rose 3.1% in its latest session, moving from $13.10 to $13.51.
What it means for Core Scientific, Inc. investors
For Core Scientific, Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Positive 3.1% session move. Weighing against that: Core Scientific fell 6.47% to $13.53, reversing recent momentum; Core Scientific fell 3.64% to $15.36 despite positive AMD approval news reported by Seeking Alpha, which framed the situation as a buying opportunity amid a broader meltdown. Wall Street's consensus price target sits at $32.75, implying +142.4% upside from $13.51. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality low (50/100). With earnings roughly 9 days out, the next report is the most likely near-term test of the move.
CORZ price reaction
CORZ last traded at $13.51, up $0.41 (+3.13%) from the previous close of $13.10. The session traded on 1.1× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $13.10 and $16.68, and it currently sits about 11% of the way up that band.
Bullish and bearish analyst opinions on Core Scientific, Inc. (CORZ)
The consensus analyst price target on Core Scientific, Inc. (CORZ) is $32.75, 142.4% above the recent $13.51. Over the past 90 days analysts logged 1 upgrade, 8 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CORZ line up.
The bullish case
- Wall Street's consensus price target of $32.75 implies +142.4% upside from $13.51.
- The Street's most bullish target is $40.00 (+196.1%).
- 1 analyst upgrade in the past 90 days, most recently Keefe, Bruyette & Woods to Outperform (2026-07-30).
- Material positive event.
- Positive 3.1% session move.
The bearish case
- Core Scientific fell 6.47% to $13.53, reversing recent momentum.
- Core Scientific fell 3.64% to $15.36 despite positive AMD approval news reported by Seeking Alpha, which framed the situation as a buying opportunity amid a broader meltdown.
- Core Scientific filed two material event disclosures (8-Ks) and an earnings report today, triggering an 8.92% intraday decline to $18.90.
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 27, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for CORZ
Frequently asked questions about CORZ
Why did Core Scientific, Inc. (CORZ) stock move?
CORZ rose 3.1% to $13.51. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did CORZ stock rise?
CORZ gained 3.13% ($0.41) versus the prior close of $13.10, last trading at $13.51 on 1.1× average volume.
When is Core Scientific, Inc.'s next earnings date?
CORZ's next earnings report is estimated for 2026-11-05 — about 9 days away.
What is the analyst price target for CORZ?
The consensus analyst price target for CORZ is $32.75, about 142.4% above the current $13.51. Over the past 90 days, analysts recorded 1 upgrade, 8 maintains, and 0 downgrades.
How BestStocks tracks CORZ
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for CORZ, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 27, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.